EPZ015666,
GSK3235025,
EPZ015666,
1616391-65-1,
(S)-N-(3-(3,4-Dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl)-6-(oxetan-3-ylamino)pyrimidine-4-carboxamide,
EPZ-015666,
EPZ 015666,
N-[(2s)-3-(3,4-Dihydroisoquinolin-2(1h)-Yl)-2-Hydroxypropyl]-6-(Oxetan-3-Ylamino)pyrimidine-4-Carboxamide,
GSK3235025,
3XV,
AK200926,
GTPL8287,
CHEMBL4060831,
SCHEMBL15825186,
AOB5167,
EX-A559,
ZKXZLIFRWWKZRY-KRWDZBQOSA-N,
BDBM177922,
N-[(2S)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-6-(oxetan-3-ylamino)pyrimidine-4-carboxamide,
MFCD28411588,
s7748,
ZINC220110600,
CS-3995,
SB17120,
GSK 3235025,
KS-0000064N,
NCGC00386436-03,
NCGC00386436-07,
BC600774,
HY-12727,
FT-0700230,
EPZ015666, >=98% (HPLC),
US9675614, 166,
4-Pyrimidinecarboxamide, N-[(2S)-3-(3,4-dihydro-2(1H)-isoquinolinyl)-2-hydroxypropyl]-6-(3-oxetanylamino)-,
D05XQD,